Trial site
Gesellschaft Fuer Epilepsieforschung
- 8running trials
- 6closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Epilepsy14 trials
- Phase
- Phase 39 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Completed6 trials
- Recruiting5 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Xenon Pharmaceuticals Inc.5 trials
- Biohaven Therapeutics Ltd.3 trials
- Praxis Precision Medicines Inc.3 trials
- Marinus Pharmaceuticals1 trial
- Neuraxpharm Pharmaceuticals S.L.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy.
Enrolling by invitation
Active, not recruiting
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Active, not recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy6 recruiting
Closed trials
Completed
Recruiting
Completed
Completed
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Terminated
Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026